West Pharmaceutical Services WST Proprietary Products — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: West Pharmaceutical Services’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's proprietary products — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is West Pharmaceutical Services's proprietary products — goodwill?
- West Pharmaceutical Services (WST) reported proprietary products — goodwill of $80M in Q4 2025.
- How has West Pharmaceutical Services's proprietary products — goodwill changed year-over-year?
- West Pharmaceutical Services's proprietary products — goodwill increased by 4.2% year-over-year, from $76.8M to $80M.
- What does proprietary products — goodwill mean?
- This represents the intangible asset value recorded when the company acquires other businesses within the proprietary products segment for a price exceeding the fair value of their net assets. It reflects the premium paid for brand equity, customer relationships, and intellectual property.